Meeting Organizer Grants
Members of FEMS Member Societies can apply for our grants. FEMS supports selected meetings within the European Area with a Meeting Organizer Grant. Scientific conferences, laboratory workshops and training courses will be considered for such support.
As an increasing number of conferences, society meetings and congresses are moving into online events, FEMS has opened the Meeting Organizer Grants (MOG) to support both virtual* and in-person meetings.
The maximum amount of a Meeting Organizer Grant is € 15 000. The Meeting Organizer Grant replaces two of our former grants: National and Regional Congresses Grant and the Meeting Grants. You will find our Grants Regulations here.
A minimum of 60% of total grant value of the Meeting Organizer Grant is to be used to support the attendance of Early Career Scientists.
*If you are organizing an online event, on the application form please indicate ‘Online’ under the Event type question.
Complete applications should be submitted on or before the deadlines:
- 1 December 23:59 CET for meetings taking place between 1 June the following year and 31 May the year after that.
- 1 June 23:59 CET for meetings taking place between 1 December that year and 30 November the following year.
How to apply
You can apply via our Grants submission system. In order to apply, you need a FEMS profile/account.
- Please create an account here or login with your credentials here.
- Once logged in to your FEMS profile, you can access the application forms for our Grants via this link.
You can also find the application forms at any time within your FEMS profile/account:
- login to your FEMS profile
- then under ‘Announcements’ click on the ‘Apply for a FEMS Grant’
- select the grant you wish to apply for
- fill in the form, save your progress and come back to it and once you are ready – Submit
FEMS Yeast Research is proud to present this latest thematic issue on yeast pathogenesis and drug resistance. In the past few decades, genetics and genomics studies have uncovered traits underlying the pathogenicity and drug resistances of pathogenic yeast. However, we still have a lot to uncover about the complex mechanisms used by different species to thrive in the human host, and much to do to convert this knowledge into improved clinical treatments. This thematic issue highlights the importance of the diversity of genome-scale approaches to unravel the intricate nature of pathogenesis and drug resistance in pathogenic yeasts, bringing together a diverse range of fascinating views on antifungal drug resistance.